Skip to main content
Signal8

BIMI International Medical Inc. (BIMI)

Sector: Medical - Distribution

Industry: Medical - Distribution

BIMI International Medical Inc. logo

BIMI International Medical Inc.

OTC:BIMIHealthcare
CLOSED
Mkt Cap$6K
EV-
Float11.59M
O/S11.56M
VOL6K sh
$ Vol$1
RVOL2.73×
Inst Own-
SI0.4%
Net Cash/Sh-
Dilution
Historical Data
DateOpenHighLowCloseVolume
Nov 4, 20260.00010.00010.00010.00015,903
Oct 28, 20260.00010.00010.00010.0001486
Oct 20, 20260.00040.00040.00040.0004100
Oct 16, 20260.00040.00040.00040.0004100
Oct 15, 20260.00030.00030.00010.0001301
Oct 6, 20260.00050.00050.00050.00053,000
Oct 2, 20260.00010.00010.00010.000110,005
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
0.0%
Institutional
(0)
0.0%
Insiderⓘ
(0)
0.0%
5%+ Owners
(0)
100.0%
Unattributed (incl. retail)ⓘ
Unattributed (incl. retail)100.0%
Sources: O/S: 11.6M · checked 8 Oct 2026 · market-data provider
About

BIMI International Medical Inc., headquartered in Chongqing, China, is an enterprise engaged in a diverse array of healthcare operations.

The company, which was established in 2000 and adopted its current name in June 2021 (formerly BOQI International Medical Inc.), focuses on the supply and sale of medical devices, pharmaceuticals, and other health-related products.

Its business activities are structured across four main divisions: wholesale pharmaceuticals, wholesale medical devices, medical services, and retail pharmacies. For its wholesale segment, BIMI distributes a wide range of specialized medical equipment, including Stryker spinal products, Olympus endoscopes, various imported imaging devices, and diagnostic imaging systems. These products are supplied to clients such as drugstores, private clinics, pharmaceutical dealers, and hospitals, particularly within China's Southwest region.

The company also facilitates the distribution of a broad spectrum of pharmaceutical products, comprising generic medications, traditional Chinese herbal remedies, biochemical drugs, essential raw ingredients for pharmaceuticals, antibiotics, cardiovascular treatments, and anti-obesity medicines. Through its "Lijiantang Pharmacy" brand, BIMI operates a network of directly-owned retail outlets. These pharmacies offer consumers an extensive selection of items, including prescription and over-the-counter drugs, nutritional supplements, health foods, sundry goods, traditional Chinese medicines, personal and family care products, and medical devices. Beyond product sales, BIMI also delivers medical services within hospital environments and undertakes IT research and development initiatives.

Key Metrics
Market Cap$5,780
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership-

No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.

SectorHealthcare
IndustryMedical - Pharmaceuticals
ExchangeOTC
CountryCNCN
IPO DateOct 18, 2006
Shares Outstanding11.56M
Authorized Shares
Float11.59M
52-Week Range
Volume
Average Daily Volume2.16K

30d Avg

2.16K

60d Avg

2.74K

90d Avg

1.99K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...